According to a Reuters report, Pfizer Inc said on Tuesday that their vaccine trial participants were showing mild-to-moderate side effects when given either the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study.
Over 12,000 study participants had received a second dose of the vaccine, Pfizer executives said on an investor conference call.
Scrutinizing SafetyThe company has enrolled more than 29,000 people in its 44,000-volunteer trial to test the experimental...
https://mfame.guru/pfizer-released-covid19-vaccine-trial-blueprint-shows-mild-side-effects/